NPD1335 is a Trypanosoma Brucei Phosphodiesterase B1 Inhibitor
Trypanosoma brucei (T.b.) rhodesiense and T.b. gambiense are endemic in sub-Saharan Africa. They are typical two causative agents of human African trypanosomiasis (HAT). The drugs for HAT treatment currently on…